Cargando…
Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational Diabetes
PURPOSE: Few pregnant women in low-resource settings are screened for gestational diabetes mellitus (GDM) using the gold standard oral glucose tolerance test (OGTT). This study compared capillary blood glucose testing with 2-h plasma glucose measurements obtained using the 75-g OGTT to screen for GD...
Autores principales: | Gallardo-Rincón, Héctor, Lomelin-Gascon, Julieta, Martinez-Juarez, Luis Alberto, Montoya, Alejandra, Ortega-Montiel, Janinne, Galicia-Hernandez, Victoria, Álvarez-Hernández, Diego-Abelardo, Ávila-Domínguez, Rosangela, Reyes-Muñoz, Enrique, Illescas-Correa, Lucía Marcela, Diaz Martinez, Daniel Alberto, Magos Vázquez, Francisco Javier, Vargas Ávila, Edwin Oswaldo, Benitez-Herrera, Alejandro Efraín, Reyes-Gómez, Diana, Carmona-Ramos, María Concepción, Hernández-González, Laura, Romero-Islas, Oscar, Mújica-Rosales, Ricardo, Tapia-Conyer, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760076/ https://www.ncbi.nlm.nih.gov/pubmed/36540348 http://dx.doi.org/10.2147/DMSO.S389420 |
Ejemplares similares
-
MIDO GDM: an innovative artificial intelligence-based prediction model for the development of gestational diabetes in Mexican women
por: Gallardo-Rincón, Héctor, et al.
Publicado: (2023) -
MIDO COVID: A digital public health strategy designed to tackle chronic disease and the COVID-19 pandemic in Mexico
por: Gallardo-Rincón, Hector, et al.
Publicado: (2022) -
Sex differences in the influence of type 2 diabetes (T2D)-related genes, parental history of T2D, and obesity on T2D development: a case–control study
por: Berumen, Jaime, et al.
Publicado: (2023) -
Development and validation of a multivariable genotype-informed gestational diabetes prediction algorithm for clinical use in the Mexican population: insights into susceptibility mechanisms
por: Zulueta, Mirella, et al.
Publicado: (2023) -
Integrated Measurement for Early Detection (MIDO) as a digital strategy for timely assessment of non-communicable disease profiles and factors associated with unawareness and control: a retrospective observational study in primary healthcare facilities in Mexico
por: Gallardo-Rincón, Héctor, et al.
Publicado: (2021)